Jack Anders - Nov 25, 2025 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Signature
/s/ Jack Anders
Stock symbol
RVMD
Transactions as of
Nov 25, 2025
Transactions value $
-$308,826
Form type
4
Date filed
11/26/2025, 04:16 PM
Previous filing
Nov 13, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Anders Jack Chief Financial Officer C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY /s/ Jack Anders 2025-11-26 0001800668

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $92.1K +5.42K +4.88% $17.00 116K Nov 25, 2025 Direct F1, F2
transaction RVMD Common Stock Sale -$401K -5.42K -4.65% $74.00 111K Nov 25, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -5.42K -100% $0.00 0 Nov 25, 2025 Common Stock 5.42K $17.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
F2 Includes 48,275 restricted stock units.